<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Dysentery</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Dysentery.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/dysentery.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Burden of Shigella infection in children under five years living in a peri-urban area of Ouagadougou, Burkina Faso: A community-based cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014624-0abee3ac/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014624-0abee3ac/</guid>
    <pubDate>Fri, 14 Aug 2026 00:00:00 GMT</pubDate>
    <description>Regional incidence estimates and strain distributions offer foundational parameters for evaluating pediatric immunization strategies and directing sanitation resource allocation.</description>
    <category>Shigellosis</category>
    <category>Dysentery</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Antimicrobial resistance</category>
    <category>Diagnostics</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Estimating the impact of Shigella vaccines on growth outcomes and implications for clinical trial design</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128908-ad399ee7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128908-ad399ee7/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Refining trial methodologies to capture developmental benefits may reinforce the clinical justification for deploying Shigella vaccines in endemic regions.</description>
    <category>Dysentery</category>
    <category>Gastroenteritis</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Qualification of a high-throughput luminescence-based Serum Bactericidal Activity assay to assess the functionality of human sera against five Shigella serotypes</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128965-8a57192f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128965-8a57192f/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The study provides an assay method for evaluating functional antibody responses during development of Shigella vaccines. The abstract places this work in the context of shigellosis burden and antimicrobial-resistance concerns, but it does not report clinical effectiveness, disease reduction, or population-level outcomes.</description>
    <category>Dysentery</category>
    <category>Shigellosis</category>
    <category>Vaccination</category>
    <category>Antimicrobial resistance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-018-03949-8-87ff49a4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-018-03949-8-87ff49a4/</guid>
    <pubDate>Fri, 13 Apr 2018 00:00:00 GMT</pubDate>
    <description>The work underscores the necessity of incorporating genetic sequencing tools across all phases of resistance tracking and control strategies.</description>
    <category>Dysentery</category>
    <category>Antimicrobial resistance</category>
    <category>Surveillance</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>ESBL-Producing and Macrolide-Resistant Shigella sonnei Infections among Men Who Have Sex with Men, England, 2015</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2211-160653-c33e9bcb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2211-160653-c33e9bcb/</guid>
    <pubDate>Tue, 01 Nov 2016 00:00:00 GMT</pubDate>
    <description>The findings document emergence of multidrug-resistant S. sonnei with combined ESBL production and macrolide resistance in a population at elevated risk for shigellosis transmission. The plasmid-mediated resistance and mobile genetic element acquisition suggest potential for ongoing resistance spread.</description>
    <category>Dysentery</category>
    <category>Influenza</category>
    <category>Shigellosis</category>
    <category>Genomic epidemiology</category>
    <category>Antimicrobial resistance</category>
    <category>Outbreak investigation</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Elevated Risk for Antimicrobial Drug–Resistant Shigella Infection among Men Who Have Sex with Men, United States, 2011–2015</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2209-160624-5e3dabaf/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2209-160624-5e3dabaf/</guid>
    <pubDate>Thu, 01 Sep 2016 00:00:00 GMT</pubDate>
    <description>The data underscore the importance of integrating sexual history assessments into routine clinical evaluations and public health investigations for enteric pathogens. Tailored educational outreach appears necessary for populations experiencing elevated resistance rates.</description>
    <category>Dysentery</category>
    <category>Shigellosis</category>
    <category>Gastroenteritis</category>
    <category>Antimicrobial resistance</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0004879-559e7743/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0004879-559e7743/</guid>
    <pubDate>Thu, 28 Jul 2016 00:00:00 GMT</pubDate>
    <description>Clinicians should rule out Entamoeba histolytica infection before prescribing corticosteroids, particularly for patients from or traveling to endemic areas and those being evaluated for inflammatory bowel disease. Improved preventative and treatment strategies are needed to reduce fulminant disease mortality.</description>
    <category>Dysentery</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Systematic review</category>
  </item>
</channel>
</rss>
